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Choy S, Wheatley A, McCormack DG, Parraga G. Hyperpolar-
ized 3He magnetic resonance imaging-derived pulmonary pressure-
volume curves. J Appl Physiol 109: 574–585, 2010. First published
June 10, 2010; doi:10.1152/japplphysiol.01085.2009.—We aimed to
evaluate the potential for the use of hyperpolarized helium-3 magnetic
resonance imaging (MRI) apparent diffusion coefficient (ADC) sur-
rogates of alveolar size, together with literature-based morphological
parameters in a theoretical model of lung mechanics to simulate
noninvasive transpulmonary pressure-volume curves. Fourteen ex-
smokers with chronic obstructive pulmonary disease (COPD) (n  8
stage II, n  6 stage III/IV COPD) and five age-matched never-
smokers, provided written, informed consent and were evaluated at
baseline and 26  2 mo later (n  15 subjects) using plethysmogra-
phy, spirometry, and 3He MRI at 3.0 T. Total lung capacity, residual
volume, and literature-based morphological parameters were used
with alveolar volumes derived from 3He ADC to simulate noninvasive
pressure-volume curves. The resultant anterior-posterior transpulmo-
nary pressure gradient was significantly decreased for stage II COPD
(P  0.01) and stage III COPD subjects (P  0.001) compared with
healthy volunteers. Both COPD subgroups showed increased alveolar
radius compared with healthy subjects (P 0.01, stage II COPD; P
0.001, stage III COPD). In addition, surface area and surface tension
were significantly increased in stage III COPD compared with healthy
volunteers (P  0.01). These results suggest that 3He MRI provides a
potential noninvasive approach to evaluate lung mechanics regionally
and further supports the use of ADC values as a regional noninvasive
probe of pulmonary microstructure and compliance.
helium-3 magnetic resonance imaging; apparent diffusion coefficient;
mathematical modeling
NONINVASIVE IMAGING METHODS provide a way to detect and
quantify pulmonary changes associated with chronic obstruc-
tive pulmonary disease (COPD) (5, 24, 27, 28, 37, 40). While
X-ray computed tomography (CT) has been the imaging tool of
choice for clinical care and research studies over the last 3
decades (5), hyperpolarized helium-3 (3He) magnetic reso-
nance imaging (MRI) offers both complementary and unique
anatomic and quantitative functional information based on the
ventilation distribution in the lung (4, 7, 23, 46) and the
measurement of structure at the alveolar level (1, 3, 7, 48).
Notably, and unique among COPD imaging methods, 3He
MRI can be used to provide quantitative information about the
relative sizes of alveoli, acinar ducts, and airways in each
volume element (voxel) through the 3He apparent diffusion
coefficient (ADC), which is related to the restriction of 3He
self-diffusion (36, 48). The 3He ADC provides a surrogate
measurement of air space size because of a number of key
characteristics of 3He gas. In particular, 3He is small with a
corresponding high self-diffusion rate (mm/ms), it is chemi-
cally inert, and cannot be transported across intact biological
tissues and membranes. Accordingly, 3He magnetic resonance
(MR) methods can be used that are sensitive to 3He gas
self-diffusion and provide a specific measure of the 3He signal
(36, 48) to generate the ADC. For diffusion times on the order
of 2–3 ms, the average displacement of helium atoms by virtue
of its self-diffusion is the same order of magnitude as alveolar
diameters (a few hundred micrometers), providing a way to
measure alveolar sizes wherever 3He gas enters on inhalation
(36). Values for 3He ADC at 3.0 T and using short diffusion
times (1–3 ms) range from 0.88 cm2/s for unrestricted free
space (akin to an infinitely large container) to 0.66 cm2/s for an
elderly COPD patient with forced expiratory volume in 1 s
(FEV1) 26% predicted (32) and 0.16 cm2/s for a young non-
smoker with FEV1 130% predicted (33). Previous studies have
shown that ADC correlates with pulmonary function (26) and
histological measurements of lung surface area (41, 47) in
COPD. Importantly, the ADC value itself has been found to be
dependent on age (13), position (15, 45), gravity (10), and
smoking history (14), and is highly reproducible over short
periods of time (29, 32). Recent studies have also shown that
the distribution of ADC is dependent on direction (15, 40), and
this dependency is different in diseased individuals, suggesting
that ADC is sensitive to both anatomic location and disease.
A proposed mechanism for the anatomic distribution of the
3He MRI ADC is the effect of the gravitational gradient on
transpulmonary pressure (Ptp) (14, 15, 40). Because our labo-
ratory previously observed significant differences in ADC
anatomic distribution between healthy subjects and stage III
COPD (10) and because it has been well-established that Ptp is
nonuniform and related to lung expansion and regional venti-
lation (25), we explored the utility of ADC values to provide
regional alveolar volumes and generate regional Ptp-volume
(PV) curves. Previously, Coxson and coworkers (6) reported
X-ray CT estimates of total and regional lung volumes and
showed that pleural pressure gradients could be determined
from the volume of gas per gram of lung tissue estimated from
X-ray attenuation values in CT scans. CT measurements of the
volume of gas per gram of tissue reflect the degree of emphy-
sematous damage and gas trapping and are conceptually sim-
ilar to the finding of regional differences in ADC measure-
ments from 3He MRI (10, 40). For example, the finding of
relatively increased ADC in the posterior slices (thus increased
alveolar size in the dependent portion of the subject) in COPD
compared with age-matched healthy volunteers might be re-
flective of increased gas trapping in these individuals.
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Here we report the use of experimental ADC data as surro-
gate measurements of alveolar size in well-established lung
micromechanical models (2, 20, 38, 42–44), reviewed in Ref.
21, to simulate Ptp gradients in healthy volunteers and COPD
ex-smokers. The lung micromechanical models used morpho-
logical parameters, such as alveolar expansion, lung volume,
lung compliance, and surface tension. Preliminary results from
this pilot study provide further evidence (41, 47) of the poten-
tial for noninvasive lung imaging measurements of regional
lung physiology.
METHODS
Study subjects. Nineteen subjects were evaluated and enrolled, as
previously described (11), from the general population of the tertiary
health care center, as well as directly from the COPD clinics at the
three local teaching hospitals. All subjects provided written, informed
consent to the study protocol, approved by the local research ethics
board and Health Canada, and the study was compliant with the
Personal Information Protection and Electronic Documents Act (Canada).
COPD subjects required a disease diagnosis of at least 1 yr, having
had a smoking history of at least 10 pack·yr. Age-matched healthy
subjects were included, if they had no history of chronic respiratory
disease, 1 pack·yr smoking history, FEV1  80% predicted, FEV1
divided by the forced vital capacity (FVC) or FEV1/FVC  70%, and
no current diagnosis or history of cardiovascular disease. Throughout
the duration of the study, COPD subjects were to be withdrawn from
the study, if they had experienced a COPD exacerbation, or if they
experienced a drop in arterial oxygen levels as monitored using pulse
oximetry below 80% for 15 continuous seconds during MRI proce-
dures. However, no subjects were withdrawn for these reasons. COPD
and healthy subjects were categorized according to Global Initiative
for Chronic Obstructive Lung Disease (GOLD) criteria (35).
Study assessments. After subjects provided written, informed con-
sent, they were screened for MRI and coil compatibility and under-
went a physical exam, plethysmography, and spirometry. Spirometry
and plethysmography were performed in the morning after patients
delayed inhaled bronchodilators and corticosteroids for 12 h, as
previously described (34). Briefly, spirometry was performed at the
MRI visit using an ndd EasyOne spirometer (ndd Medizintchnik AG,
Zurich, Switzerland), reporting FEV1 (absolute and percent predicted)
and FVC. COPD subjects performed spirometry at a pre-MRI screen-
ing visit (pre- and postbronchodilator) and were enrolled based on the
postbronchodilator FEV1 measurement that was, furthermore, re-
quired to be within 3% of prebronchodilator FEV1, eliminating the
potential for underlying asthma to confound results. Whole body
plethysmography (MedGraphics, St. Paul, MN) was performed im-
mediately before MRI for the measurement of total lung capacity
(TLC), inspiratory capacity (IC), residual volume (RV), and func-
tional residual capacity (FRC).
Hyperpolarized 3He administration. For each subject, vital signs
were measured, and arterial O2 levels were recorded before pre-MRI
in the supine position to ensure the subject could tolerate MR
scanning in a supine position. Spirometry was performed, as per
American Thoracic Society standard, with the subject seated upright.
Subjects were administered a practice dose of mixed 4He-nitrogen
while seated outside the scanner. Digital pulse oximetry was used to
monitor arterial blood oxygenation levels during MR scanning and all
breath-hold maneuvers. Hyperpolarized 3He gas was provided by a
turnkey, spin-exchange polarizer system (HeliSpin, GEHC, Durham,
NC). In a typical study, this system provided 30% polarization in 12
h. Doses (5 ml/kg) were delivered in 1-liter plastic bags (Tedlar,
Jensen Inert Products, Coral Springs, FL), diluted with ultrahigh
purity, medical grade nitrogen (Spectra Gases, Alpha, NJ). Polariza-
tion of the diluted dose was quantified by a polarimetry station
(GEHC, Durham, NC). 3He MR scans were acquired during an
inhalation breath hold after inspiration from RV of a 1-liter 5 ml/kg
dose of 3He mixed with N2. Post-MRI spirometry was also performed
for all subjects.
Imaging. MRI was performed on a whole body 3.0-T Excite 12.0
MRI system (GEHC, Milwaukee, WI) with broadband imaging capa-
bility, as previously described (34). All helium imaging employed a
whole body gradient set with maximum gradient amplitude of 1.94
G/cm and a single-channel, rigid elliptical transmit/receive chest coil
(RAPID Biomedical, Wuerzburg Germany). The basis frequency of
the coil was 97.3 MHz, and excitation power was 3.2 kW using an
AMT 3T90 RF power amplifier (GEHC, Milwaukee, WI).
A flip angle of 7° was used, and 3He multislice images were
obtained in the coronal plane using a fast gradient-recalled echo
method with centric k-space sampling (14). Two interleaved images
(echo time  3.7 ms, repetition time  7.6 ms, 128  128, 7 slices,
30 mm thick, field of view  40 cm  40 cm), without and with
additional diffusion sensitization (maximum gradient amplitude G 
1.94 G/cm, rise and fall time  0.5 ms, duration  0.46 ms, b value
 1.6 s/cm2) were acquired for each slice. All scanning was com-
pleted within 7 min of the subject first lying in the scanner.
Image analysis. ADC images were analyzed by a single trained
observer in an image visualization environment with room lighting
levels equivalently established for all image analysis sessions. Mean
ADC and ADC maps were processed using in-house software pro-
grammed in the IDL Virtual Machine platform [Research Systems,
Denver, CO, as previously described (34)]. Briefly, the major airways
were manually segmented from the images with both lungs remaining
for analysis. The MR signal intensity acquired without diffusion
sensitization (S0) and the MR signal intensity acquired with diffusion
sensitization (S) were used to calculate ADC, where b  1.6 s/cm2, as
described in Eq. 1:
ADC
lnS0S 
b
(1)
Five center slices or regions of interest (ROI) were examined, as
shown schematically in Fig. 1, and the arithmetic mean and standard
deviation (SD) of ADC were calculated from ADC histograms.
Theory for generation of alveolar volume. Acinar duct dimensions
were generated from mean ADC values following a method described
by Yablonskiy et al. (48). Briefly, the transverse attenuation exponent
(T) was used as a function of the acinar duct radius (R) and values
of T were directly calculated using Eq. 2:
T 
4GmR22
D0
j
1j
4
1j2  1
QD0R2 1j2 ,  ,  (2)
The function Q was calculated as provided in equation 3 as:
Q(	, 
, ) 1 4
3
 
2
	32
[exp(	) 	  1]

4
	32
sin h2	2 exp	(1 
 2 sin h2		(1 )2 
exp(	
)
(3)
where   D0	ij2
/R2,   /
, and ε /
,   2.04 108 s1, T1
(gyromagnetic ratio), Gm  1.95  104 T/s (maximum gradient
amplitude), D0  0.88 cm2/s (free diffusion constant of 3He), 	1j is
the jth root of the first-order Bessel function, 
  1.46 ms (gradient
pulse duration),   2.94 ms (diffusion time), and   0.50 ms (ramp
time).
We used a similar assumption and approximated equation (2) using
the first term in the sum, because the ratio R/l0 was  2. The R was
previously reported by Haefeli-Bleuer and Weibel (18) to be 350
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m, and the characteristic diffusion length l0 for helium atoms was
720 m for the diffusion time used in this study (2.94 ms).
Additionally, the transverse attenuation exponent was calculated in
relationship to the transverse diffusion coefficient (DT) described in
Eq. 4 by:
DT 
T
b
(4)
Yablonskiy related the DT and longitudinal diffusion coefficient (DL)
with mean diffusion coefficient (DM) by considering the acinar duct as a
cylindrical object consisting of a tube embedded in the alveolar sleeve
(Fig. 2), according to Haefeli-Bleuer and Weibel (18). This geometry
gave rise to the following relationship described by Eq. 5:
DM 
1
3
DL 
2
3
DT (5)
For the purposes of this study, DM  ADC, and ratio of DL to DT
(DL/DT) for healthy and emphysematous subjects was determined em-
pirically to be 3 (48). Thus Eq. 5 takes the form described by Eq. 6:
DT 
3
5
ADC (6)
and relating this to Eq. 4 gives rise to Eq. 7:
T 
3
5
ADC · b (7)
To estimate R, values of T were calculated over a range of radii (R)
using Eq. 2. Mean ADC was used in Eq. 7, and b was set to 1.6 s/cm2,
which sets the right side of Eq. 7 to a single number. The chosen R
produced a value of T that satisfied Eq. 7. The alveolar radius (L) was
estimated to be one-third the R of the acinar duct, based on published
morphometry estimates reported by Ingenito et al. (21).
It is important to note the dependence of Eq. 7 on diffusion time as
it assumes the diffusion length is on the order of the alveolar duct
diameter. For diffusion time slightly larger or shorter than the one
presented, one would expect a decrease in ADC and a simultaneous
decrease in T, which is itself dependent on diffusion time. The net
effect is that the resulting R should remain similar. At extremely long
or short diffusion time, different lung structures will be probed (17),
which would likely bias the calculation of R. To the author’s knowl-
edge, there has been no analysis on an optimal diffusion time for
probing the R. For our diffusion time of 2.94 ms, the diffusion length
is 720 m, which is very similar to the diameter of a human acinar
duct (18).
Theory for generation of PV curves. PV curves were simulated
using the micromechanical model derived by Stamenovic (38) and
validated by Ingenito et al. (21) using published morphometry and
biomechanical data. Ptp was expressed as related to lung volume (V)
by Eq. 8 as follows:
Ptp(V) N F(L)L
3V

2
3
(S)S
V

n F(l)l
3V
(8)
The first term is the contribution of the peripheral tissue network,
which extends from the pleura into the parenchyma. The network is
modeled as N distinct line elements of length L, each contributing a
force F(L) upon stretching. According to Ingenito et al. (21), N is
equivalent to the number of alveoli, and L is equivalent to the average
L. The second term describes the contribution of surface tension in the
alveoli. The entire surface area S of the alveoli is covered with
surfactant, which has a surface tension (S) that varies with S. The
relationship between S and (S) is shown in Table 1 and is adapted
from Ingenito et al. (21). The third term describes the contribution of
the alveolar duct network, which Stamenovic (38) approximated by a
series of circular rings embedded in the alveolar duct wall. Similar to
the first term, there are n distinct rings of circumference l that
contribute a force F(l). The force-length relationship F(L) and F(l)
Fig. 1. Helium-3 (3He) magnetic resonance imaging (MRI) for calculation of mean apparent diffusion coefficient (ADC) for regions of interest. 3He
diffusion-weighted MRI was acquired on a slice-by-slice basis. ADC maps were generated from the five center slices by computing ADC on a pixel-by-pixel
basis. ADC histograms (y  frequency, x  ADC value) were generated for each slice to derive mean ADC and standard deviation.
Fig. 2. Weibel acinar duct model. The schematic illustrates the structure of the
acinar duct, considered as a cylinder with radius (r) surrounded by numerous
alveoli (open circles) that form an alveolar sleeve. The combined radius of the air-
way and alveolar sleeve is the acinar duct radius (R), and the radius of the alveoli
is L. The transverse (DT) and longitudinal diffusion coefficient (DL) are compo-
nents of the mean ADC.
Table 1. Relationship between surface area and surface
tension
S, cm2 (S), dyn/cm
965,096 25.5
848,229 22
738,901 17.5
637,114 14
542,866 10.5
456,158 7
376,990 3.5
305,362 0
S, surface area; (S), surface tension.
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were taken from the work of Fukaya et al. (16), experimentally
derived from strips of parenchymal tissue, and are expressed explicitly
by Ingenito (21). The number of alveolar ducts is estimated by
Ingenito to be one log less than the number of alveoli (N). The ducts
themselves contain a number of force-bearing fibers, and each fiber is
then modeled as a series of alveolar duct rings. Thus we approximate
the total number of alveolar duct rings (n) to be equal to the number
of alveoli (N).
Parameter values for the model were obtained that were represen-
tative of disease status. L was previously estimated from ADC
measurements, which were obtained from 3He scans at a static volume
of RV 1 liter. N was computed at RV 1 liter, assuming the alveoli
were spherical, and contributed to the entire lung volume. Subsequent
values of L at arbitrary volumes V were calculated given N 
constant. n, S, and (S) were calculated following the relationships
described by Ingenito: n  N, S was calculated assuming each alveoli
was spherical with radius L, and (S) was calculated using experi-
mental data from Ingenito (21). It was assumed that the relationship
between (S) and S was not changed due to emphysematous damage.
For the calculation of F(L) and F(l), we used the form described by
Ingenito in Eq. 9.
F(L)  LL0  1exp	4.5 LL0  1
 (9)
where L0 is the alveolar radius, and l0 is the duct ring circumfer-
ence at RV.
Exponential analysis. PV curves can be described between TLC
and 50% TLC by the exponential function (9, 21) provided in Eq. 10:
V(P) Vmax (Vmax Vmin)exp(kP) (10)
where V is volume, P is Ptp, and k is the shape factor, which was
previously described as a volume-independent index of pulmonary
elasticity (9). We fitted each curve to Eq. 10 using an iterative least
Table 2. Study subject demographics
Healthy Volunteers Stage II COPD Stage III COPD
n 5 8 6
Age (range), yr 69  6 (58–74) 68  6 (59–74) 68  6 (62–75)
Male sex, no. 2 4 4
Body mass index
(range) 25  2 (24–29) 29  4 (26–38) 26  5 (19–34)
FEV1, % 110  23 64  8a 37  6b,c
FEV1/FVC, % 77  4 55  11d 33  8b,e
IC, % 106  18 97  18 77  20
RV, % 95  15 142  22 234  111
FRC, % 101  12 116  15 189  79
TLC, % 105  12 107  10 137  52
Values are means  SD; n, no. of subjects. COPD, chronic obstructive
pulmonary disease; FEV1, forced expiratory volume in 1 s; %, percent predicted;
FVC, forced vital capacity; IC, inspiratory capacity; RV, residual volume; FRC,
functional residual capacity; TLC, total lung capacity. aP  0.001 for stage II
COPD compared with healthy volunteers. bP  0.001 for stage III COPD
compared with healthy volunteers. cP  0.01 for stage III COPD compared with
stage II COPD. dP  0.01 for stage II COPD compared with healthy volunteers.
eP  0.001 for stage III COPD compared with stage II COPD.
Fig. 3. Representative healthy subject’s and
stage III chronic obstructive pulmonary dis-
ease (COPD) subject’s 3He MRI ADC maps
and histograms. Representative data are
shown for one healthy elderly volunteer (A)
and one subject with stage III COPD (B). For
each subject, five 3He diffusion-weighted
MRI center slices (i) generated five ADC
maps (ii) and ADC histograms (iii).
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squares method, and extracted the shape factor k to compare our
results across COPD cohorts and with the literature.
Statistics. Means for ADC and ADCSD were calculated as the
arithmetic mean of the histogram describing each and every pixel
value ADC vs. frequency. Comparison of subgroup demographics,
which include age, body mass index, FEV1 %predicted, FEV1/FVC,
IC %predicted, RV %predicted, FRC %predicted, and TLC %pre-
dicted, were performed using a one-way ANOVA with GraphPad
Prism version 4.00 (GraphPad Software, San Diego, CA). Paired
t-tests were used to compare the mean k values of the simulated PV
curves that were systematically altered by changes in RV, TLC, ADC,
and . Mean values of k at baseline and follow-up were also compared
using ANOVA. For multiple comparisons, Fishers least significant
difference post hoc test was used. In all statistical analyses, results
were considered significant when the probability of making a type I
error was 5% (P  0.05).
RESULTS
Study subjects. Baseline demographic characteristics are pro-
vided in Table 2 for the 19 subjects enrolled (10 men) and
show that the mean age and body mass index for each subgroup
were not significantly different. As the COPD subjects and
healthy volunteers were enrolled based on FEV1 and FEV1/
FVC, according to GOLD criteria (35), the mean values for
FEV1 and FEV1/FVC for each subject subgroup reflect the
GOLD criteria categorization; a one-way ANOVA showed
these were significantly different between all subject groups. In
addition, ANOVA showed that RV was significantly different
for stage III COPD compared with healthy (P  0.01); FRC
was significant different for stage II and stage III COPD
compared with healthy (P 0.05). IC and TLC were decreased
and increased, respectively, for both COPD cohorts compared
with healthy elderly; however, neither change was statistically
significant.
3He MR images. Hyperpolarized 3He MRI spin-density im-
ages (Fig. 3, Ai and Bi), 3He ADC maps (Fig. 3, Aii and Bii),
and corresponding ADC histograms (Fig. 3, Aiii and Biii) are
shown for two representative subjects: one elderly healthy
volunteer (subject A) and one subject with stage III COPD
(subject B). For all subjects, and as previously described (10),
a paired t-test showed that ADC values were significantly
greater (P  0.01) in the most anterior compared with the most
posterior slices. The signal-to-noise ratio (SNR) for each slice
was computed by taking the average signal intensity of a region
in the lung slice and dividing by the standard deviation of the
Table 3. Subject listing of ADC and related parameters
RV TLC
Subject No. ADC (mean  SD), cm2/s % Liters % Liters RV/TLC DT, cm2/s R, mm L, mm VA, mm3
1001 0.25  0.18 88 2.11 102 7.46 0.28 0.150 0.362 0.121 0.0074
1003 0.28  0.17 75 1.47 90 4.15 0.35 0.168 0.375 0.125 0.0082
1004 0.25  0.17 93 1.86 123 5.77 0.32 0.150 0.362 0.121 0.0074
1007 0.30  0.22 103 2.63 102 6.36 0.41 0.180 0.384 0.128 0.0088
1008 0.25  0.17 116 2.22 107 4.53 0.49 0.150 0.362 0.121 0.0074
2001 0.50  0.23 148 3.02 99 4.67 0.65 0.300 0.463 0.154 0.0154
2002 0.41  0.21 157 3.08 111 4.88 0.63 0.246 0.429 0.143 0.0122
2003 0.29  0.19 132 3.71 99 8.1 0.46 0.174 0.380 0.127 0.0085
2005 0.40  0.21 164 4.25 120 7.93 0.54 0.240 0.425 0.142 0.0119
2006 0.49  0.24 116 2.22 106 5.19 0.43 0.294 0.459 0.153 0.0150
2007 0.46  0.30 116 2.25 94 4.30 0.52 0.276 0.448 0.149 0.0139
2008 0.36  0.19 174 4.05 120 8.09 0.50 0.216 0.410 0.137 0.0107
2009 0.30  0.23 132 3.32 109 8.31 0.40 0.180 0.384 0.128 0.0088
3001 0.50  0.26 265 6.99 146 9.60 0.73 0.300 0.463 0.154 0.0154
3002 0.44  0.20 212 5.13 124 8.58 0.60 0.264 0.441 0.147 0.0133
3004 0.34  0.22 94 2.67 78 6.01 0.44 0.204 0.401 0.134 0.0100
3005 0.47  0.24 210 4.18 132 6.56 0.64 0.282 0.452 0.151 0.0143
3008 0.47  0.28 193 5.23 111 8.37 0.62 0.282 0.452 0.151 0.0143
3009 0.58  0.30 431 7.43 231 9.64 0.77 0.348 0.491 0.164 0.0184
ADC, apparent diffusion coefficient; DT, transverse diffusion coefficients; R, acinar duct radii; L, alveolar radii; VA, alveolar volume. Healthy subjects, 1000’s;
COPD stage II subjects, 2000=s; COPD stage III subjects, 3000=s.
Table 4. Micromechanical model equation parameters
Parameter Healthy Volunteers Stage II COPD Stage III COPD
n 5 8 6
V, cm3 3,060  430 4,240  760 6,270  1,770
S, 104 cm2 75  10 91  21 120  30
N,  108 alveoli 3.9  0.5 3.7  1.3 4.3  0.6
R, mm 0.123  0.003 0.142  0.011 0.150  0.010
R0, mm 0.108  0.004 0.129  0.008 0.141  0.012
, dyn/cm 18  4 23  7 34  9
Values are means  SD; n, no. of subjects; V, volume; N, alveolar number;
R, alveolar radius; R0, radius at residual volume; , surface tension. All values,
except R0, are computed at a lung volume of RV  1 liter.
Table 5. Results from micromechanical model
Parameter Healthy Volunteers Stage II COPD Stage III COPD
n 5 8 6
Ralv, mm2 0.150  0.010 0.161  0.009 0.164  0.004
S/V, cm1 200  13 190  10 183  5
, dyn/cm 30  6 33  11 41  8
Ptissue, %Ptp at TLC 4.0  0.5 2.8  0.6 1.6  1.0
Psurface, %Ptp at TLC 20  10 45  13 68  20
Pduct, %Ptp at TLC 75  10 52  12 30  19
Ptp, cmH2O 23  11 10  4 8  2
k, cmH2O1 0.044  0.006 0.080  0.009 0.087  0.008
Values are means SD; n, no. of subjects; Ralv, alveolar radius; S/V, S-to-V
ratio; Ptissue, contribution of peripheral tissue network to transpulmonary
pressure (Ptp); Psurface, contribution of alveolar surface tension; Pduct, contri-
bution of duct rings; k, shape factor from exponential analysis. All values,
except k, are reported at TLC and derived from the mean ADC value of five
center slices.
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noise level () in a 20  20 pixel region of background. The
SNR of the five center slices were averaged to get an average
SNR for each subject. The average subject SNR was 35 and,
therefore, unlikely to have affected ADC values.
Generation of L. Table 3 provides a list of mean center slice
ADC, DT, R, L, and alveolar volume for each subject. DT was
computed from ADC using Eq. 6, and the R was subsequently
computed using Eqs. 2 and 7.
Generation of simulated PV curves. The values for the
parameters used in the micromechanical model were computed
based on L and RV (Table 4). Both COPD subgroups showed
increased L compared with healthy elderly (one-way ANOVA,
P  0.01, stage II COPD; P  0.001, stage III COPD), which
is characteristic of emphysematous damage in COPD. S and
(S) were significantly increased in stage III COPD compared
with healthy subjects (one-way ANOVA, P  0.01 for both
parameters). Table 5 shows the results provided by the micro-
mechanical model.
PV curves for the two representative subjects shown in Fig.
3 (one healthy volunteer and one subject with stage III COPD)
are provided in Fig. 4, as well as the contribution of each term
in Eq. 8 to total Ptp (right plot, Fig. 4). The anterior-posterior
Ptp gradient was calculated as the difference in Ptp (at TLC)
between the most anterior and posterior slices and dividing the
difference by the mean Ptp. This anterior-posterior Ptp gradient
was decreased significantly in stage II COPD and stage III
COPD subjects compared with healthy elderly (one-way
ANOVA, P  0.05 and P  0.01, respectively). Figure 5
shows PV curves for all subjects using the mean ADC value of
five center slices for the calculation of L. The value of k was
derived by least squares fitting of each PV curve to Eq. 10, and,
in COPD, this was significantly increased compared with that
in healthy volunteers (one-way ANOVA; P  0.05, stage II
COPD; P  0.01, stage III COPD).
We also evaluated four input parameters to better understand
their effect on the simulated Ptp curves, and these results are
shown in Fig. 6. Specifically, RV, TLC, and mean ADC for a
representative healthy subject are shown altered between 20
to 20% to simulate significant changes in these values within
the model; Ptp was calculated for each of these cases (Fig. 6,
A–C). (S) was also varied by multiplying (S) at each lung
volume with a scaling constant (Fig. 6D). These results show
that 20% changes in ADC (P  0.0001), TLC (P  0.02), and
RV (P  0.0001) resulted in significant changes in the value of
k. However, a 20% change in (S) lead to no significant change
in k (P  0.37). It is important to note that these changes
represent theoretical error in the model that are greater than the
95% confidence intervals for measurement error that we pre-
viously measured (i.e., precision for TLC and RV using coef-
ficients of variation ranging were 1–3% and ADC coefficients
of variation  0.5%).
Fig. 5. Simulated PV curves for all subjects. PV curves for healthy volunteers
(dashed line), stage II COPD (solid line), stage III COPD (dotted line) were
generated from the mean ADC measurement of five center slices.
Fig. 4. Representative transpulmonary pressure (Ptp)-
volume (PV) curves. PV curves for the same subjects
shown in Fig. 3 (A: healthy elderly subject; B: stage III
COPD subject) were generated for each of five center
slices using Eq. 8 (left). The histogram (right) shows the
relative contribution of each term in Eq. 8 to Ptp. TLC,
total lung capacity; FEV1, forced expiratory volume in 1
s; RV, residual volume; Ptiss, tissue pressure; Palv,
alveolar pressure; Pducts, duct pressure.
Innovative Methodology
5793He MAGNETIC RESONANCE IMAGING PV CURVES
J Appl Physiol • VOL 109 • AUGUST 2010 • www.jap.org
Downloaded from journals.physiology.org/journal/jappl at Univ Western Ontario (129.100.044.207) on March 4, 2020.
In Fig. 7, simulated PV curves are provided for three
representative subjects who returned 2 yr later for follow-up
[Fig. 7, Ai (healthy volunteer), Bi (stage II COPD), and Ci
(stage III COPD)], reflecting the changes in mean ADC, RV,
and TLC that occurred during that time period for each subject.
The accompanying histograms illustrating the contribution of
each term in Eq. 8 are also shown for each subject at baseline
(Fig. 7, Aii–Cii) and follow-up (Fig. 7, Aiii–Ciii). Baseline and
follow-up k values by subject group are provided in Table 6
and showed no significant change; however, the S-to-volume
ratio was significantly decreased for stage II COPD patients at
follow-up (paired t-test, P  0.03).
Effects of model assumptions on PV curves. Several assump-
tions were made to derive PV curves, and we have evaluated
the sensitivity of the model to these assumptions. Similar to the
previous section, we set the model input parameters to repre-
sentative values for a healthy subject and vary several key
parameters to measure their effect on the shape factor k.
The DL/DT was approximated as 3 to derive Eq. 6; however,
there is some physiological variability in healthy subjects and
patients with severe emphysema, as demonstrated by Yablon-
skiy et al. (48). Based on that work, we altered DL/DT from 2.5
to 4.0, which represent the most extreme values of the DL/DT
that were presented. The ratio of the L to R (L/R) was also
assumed to be constant in our model, with a value of 0.333,
while work by Sukstanskii and Yablonskiy (39) estimated that
L/R could vary by 20% in healthy and slightly emphysematous
human lungs. Accordingly, we varied L/R by 20%. In Eq. 8,
we assume that each alveoli can be represented as a sphere, and
that the number of duct ring fibers n is equal to the number of
alveoli N. We tested the assumption of spherical alveoli by
varying the shape to a three-fourth sphere or one-half sphere.
The relation between n and N was varied arbitrarily by 20%.
Numerical results of model sensitivity to these assumptions
are summarized in Table 7. The model was insensitive to
changes in the DL/DT and deviated by 10.9% when DL/DT
was set to 4. Conversely, the model was extremely sensitive to
changes in L/R, with a 20% reduction in L/R producing a
43.6% reduction in k. Altering the alveoli shape had a large
effect as well, and shifting from a spherical model to a
hemispherical model decreased k by 45.5%, although shifting
to a three-fourth spherical model only decreased k by 18.9%.
Finally, the model was moderately sensitive to changes in the
ratio n/N, with a 20% increase and decrease in the ratio causing
a 15.8% decrease and 18.8% increase in k, respectively.
Effects of heterogeneity on model results. The microme-
chanical model operates on the assumption that each physio-
logical parameter can be estimated by a single average value,
and that the entire lung can be represented by average param-
eters. However, in emphysema, there are regional differences
in tissue properties, which may affect the simulated whole lung
PV curve. To test for the effects of this heterogeneity, we
divided the center slice of a representative COPD stage III
subject into four compartments and eight compartments
Fig. 6. Testing the model. PV curves were gener-
ated for a single healthy elderly volunteer using
ADC  20% (A), RV  20% (B), TLC  20%
(C), and surface tension ()  20% (D).
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(Fig. 8). Local physiological parameters and PV curves were
generated independently for each compartment. Mean ADC in
each compartment differed slightly compared with the mean
ADC of the entire center slice, with the average deviation
being 4.5% for four compartments and 5.7% for eight com-
partments.
PV curves were generated independently for each compart-
ment (Fig. 9, shaded areas), and also for the center slice using
averaged parameters. PV curves for individual compartments
were found to differ slightly from the center slice PV curve;
however, the k value of any compartment did not deviate by
3% from the k value of the center slice PV curve. The
average PV curve of all of the compartments was nearly
identical to the center slice PV curve (Fig. 9).
DISCUSSION
In this small pilot study of COPD ex-smokers and healthy
age-matched never-smokers, we aimed to develop a way to
generate transpulmonary PV curves based on micromechanical
models of the lung, plethysmography measurements of lung
volumes, and 3He MRI ADC values. Accordingly, we report
the following: 1) the use of 3He MRI ADC to estimate average
alveolar dimensions in specific ROI; 2) application of ADC mea-
Fig. 7. Longitudinal PV curves. PV curve plots (i) illustrate changes in Ptp for each subject from baseline to follow-up. Histograms were generated for baseline
(ii) and follow-up (iii). A: healthy; B: stage II COPD; C: stage III COPD.
Table 6. Comparison of 3He MRI-derived PV curve parameters at baseline and follow-up
Baseline Follow-up
n k, cmH2O1 S/V, ml1 k, cmH2O1 S/V, ml1
Healthy elderly 3 0.049  0.013 204  15 0.030  0.006 226  13
Stage II COPD 7 0.079  0.027 187  10 0.084  0.016 176  10
Stage III COPD 5 0.083  0.019 182  5 0.090  0.020 176  11
Values are means  SD; n, no. of subjects. S/V is at TLC.
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surements in an established lung tissue micromechanical model to
generate regional transpulmonary PV curves; 3) comparison of
transpulmonary PV curves for specific ROIs in healthy elderly
and COPD subjects; and 4) comparison of baseline and fol-
low-up PV curves for subjects who returned 2 yr later. To
our knowledge, this is the first application of hyperpolarized
3He ADC for the generation of noninvasive transpulmonary
PV curves with the evaluation of ROI and longitudinal differ-
ences.
First, we derived the number of alveoli and mean alveolar
dimension from ADC measurements following the work of
Yablonskiy et al. (48). 3He images were likely not biased due
to low SNR and, therefore, the resulting ADC measurements
likely reflected disease severity and not noise level (31). We
observed significant differences in alveolar dimensions be-
tween healthy subjects and those with stage II and stage III
COPD; however, as shown in Table 3, alveolar number was not
significantly different for either COPD group compared with
the healthy volunteers. This observation may be partly ex-
plained by the variability of ADC values across COPD sub-
jects, suggesting that, within a single GOLD group, there are
different disease processes that reduce lung function without
concomitantly reducing alveolar number (e.g., chronic bron-
chitis). Another possible explanation is related to the diffu-
sion time used in this study; acinar duct dimensions were
likely probed, and, to estimate L, we assumed a constant
relationship between L and R, regardless of disease state,
although this specific relationship was previously derived
from normal lung (21).
Second, using L dimensions in the Stamenovic model, we
generated transpulmonary PV curves, and, as might be ex-
pected, there were significant differences in PV curves for
healthy and COPD subjects. (S) also appeared to provide a
greater proportion of recoil pressure in COPD subjects (Fig. 4),
and, as shown in Table 5, (S) contributed to 20% of the
recoil pressure for healthy subjects, 45% for stage II COPD
subjects, and 68% for stage III COPD subjects. This result is in
agreement with previous work of Ingenito and colleagues (21),
who reported that tissue recoil forces decreased rapidly in
emphysema, while (S) remained an important contributor to
Ptp. The increase in (S) derived for the COPD subjects in our
study was directly related to the increase in total S (Table 4),
which is contrary to results reported by Ingenito et al. that
demonstrated a decrease in S in COPD. One explanation for
this discordant result is that, in the present study, S was derived
from the micromechanical equations, and that its calculation
was more strongly influenced by the degree of hyperinflation
reported for COPD subjects compared with the decreased S
predicted by the high ADC values that reflected enlarged air
spaces in the COPD patients. Similarly, surface area-to-volume
ratio values predicted from our simulations were larger than
those reported by Ingenito et al.
It is important to note that k values predicted from our
simulated PV curves were lower than those previously pro-
posed by Ingenito et al. (21). One contributing factor to the
apparently lower k values we report in this study may be
attributed to the diminished simulated alveolar tissue recoil
force, which represented a significant portion of Ptp in the
previous analysis (21). The loss of this portion of recoil
pressure flattens the simulated PV curves we present here,
which subsequently lowers k. Another noteworthy difference
between our result and previous work (21) is that (S) was not
equal to 0 dyn/cm at RV, perhaps reflecting the significant gas
trapping for the COPD patients in our study that may have lead
to residual recoil pressure at RV.
Third, we showed significant differences in Ptp gradients in
the anterior-posterior direction (Fig. 4), which may reflect the
postural changes in ADC previously described (10). We also
observed that both COPD cohorts had significantly reduced
gradients compared with a healthy age-matched cohort (P 
0.01, stage II COPD and P  0.001, stage III COPD). We have
previously reasoned that, in COPD subjects, gas trapping in
the posterior portion of the lung makes the air spaces less
compressible, which reduced the anterior-posterior gradient
compared with healthy volunteers. It was previously estab-
lished in a number of studies (8, 11) that higher lung inflation
levels increase ADC values. This effect is also observed in
COPD subjects, where gas-trapped posterior lung regions have
higher ADC values than what might be predicted. With gas
Table 7. Sensitivity of model results to key parameters
Parameter k, %
Normal: DL/DT  3
DL/DT  2.5 8.3
DL/DT  4 10.9
Normal: L/R  0.333
L/R  0.27 43.6
L/R  0.40 35.8
Normal: spherical alveoli
Three-fourths spherical 18.9
One-half spherical 45.5
Normal: n  N
n  0.8 N 18.8
n  1.2 N 15.8
k, %, Percent change in k from normal. DL/DT, ratio of longitudinal
diffusion coefficient to transverse diffusion coefficient; L/R, ratio of L to R; n,
number of duct rings; N, number of alveoli.
Fig. 8. Mean ADC and standard deviation
for a center slice and each compartment.
Mean ADC values are given in cm2/s, and
standard deviations (in parentheses) are re-
ported for the center slice and each compart-
ment of a single COPD stage III subject.
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trapping, elevated recoil pressures would result in decreased
Ptp gradients.
Finally, we also demonstrated the utility of 3He MRI-
derived PV curves for longitudinal analysis (Fig. 7) and
showed that changes in ADC, RV, and TLC for some subjects
resulted in significant alterations in surface area-to-volume
ratio. We also expect that, with a greater number of longitu-
dinal study subjects, significant changes in k may be detected.
When comparing longitudinal PV curves, however, it is im-
portant to note that parameter analysis (Fig. 6) showed the
sensitivity of the curves to RV and TLC, pointing out the
importance of consistency in longitudinal plethysmography
measurements. The change in PV curves for one healthy subject
(Fig. 7A) is likely due to this sensitivity. This particular patient
had a large decrease in RV/TLC from baseline to follow-up (0.41
to 0.33), which would cause a large increase in Ptp. Nonphysi-
ological differences in lung inflation were controlled by having
each subject rehearse the breath-hold maneuver while seated
outside the MR scanner and once while inside the scanner.
We recognize and acknowledge a number of important
limitations of this work. Compared with previous work (21)
that demonstrated that the peripheral tissue network contrib-
uted 50% of Ptp in normal subjects and at least 20% in
emphysema, the contribution of the peripheral tissue network
to Ptp is likely underestimated (4% for healthy elderly and
2.8% for COPD) in our analysis. We expected that, in accor-
dance with this previous work, peripheral tissue would con-
tribute to almost one-half of the pressure in the lung, especially
for the healthy volunteers with intact peripheral lung tissue,
which allows for a large expansion from RV to TLC, and
furthermore allows the peripheral lung tissue to stretch and
generate recoil. However, none of the COPD subjects in this
study showed such large lung expansion, and even the young-
est never-smoker (aged 58 yr at baseline) reported a RV/TLC
of 0.28 (RV  2 liters, TLC  7 liters).
This may have resulted because of the small recoil pressures
due to the minimal stretching of the peripheral fibers (calcu-
lated recoil forces  5.5 dyn in our dataset), creating a
maximum recoil pressure of 2.2 cmH2O. One possible im-
provement to the model is to include the recoil force generated
by the pleural membrane into the peripheral tissue system, and
we note that Hajji et al. (19) previously reported that the
tension in the pleural membrane contributed20% of the work
performed by the lung during deflation. We also recognize that
the relationship between (S) and S in COPD is not well
understood. While it is commonly recognized that the (S)-S
curve changes nonlinearly with inspiration vs. expiration, we
used an approximate linear relationship to represent the (S)-S
curve. In addition, using a single (S)-S relationship for both
healthy and COPD lungs may not be appropriate, because this
implies that the slow expansion of an alveolus in emphysema
might be similar to a single stretch of an alveolus during
respiration, but the two are likely somewhat different physio-
logical processes. To our knowledge, there have been no
studies that experimentally measure (S)-S curves for healthy
elderly with comparison to COPD subjects, and characteriza-
tion of changes in the intrinsic properties of surfactant in
disease is incomplete. It is worth noting, however, that recent
work has shown no change in surfactant in emphysematous
elastase-treated mice (30). In the future, it will be important to
account for interdisease and intersubject differences in (S).
Another limitation that is important to note is the fact that ADC
values only reflect those regions of the lung that are ventilated,
which limits the utility of the ADC measurement to only those
areas of the lung that can be ventilated during the timeframe of
the MR scan. Those regions that cannot be ventilated due to
bullae, gas trapping with long time constants, or closed or nar-
rowed airways do not report ADC values, which certainly is a
limitation of this approach in subjects with very poor ventilation.
A number of assumptions in the model and the selection
of model parameters certainly affect our results and warrant
discussion, as shown in Table 7. The first assumption was to
set DL/DT to 3 for all subjects. This approximation was
necessary, since image data were only acquired at two b
values (0 and 1.6), and ADC was computed using a mono-
exponential model. In the multi-b value method proposed by
Yablonskiy et al. (48), the mean and anisotropic ADCs can
be calculated to deduce both DL and DT. Despite this
simplistic assumption and ignoring diffusion anisotropy, the
physiological variability of DL/DT only weakly affected the
resulting PV curve. The shape factor k deviated by 10.9% in
the worst case estimated of DL/DT (Table 7). Furthermore,
DT is relatively insensitive to changes in b value (39), thus
there is minimal error in DT due to its calculation using only
two small b values. We had also assumed that the L/R was
constant, regardless of disease status, which may not be true
for severely emphysematous lungs. This approximation
could introduce relatively large error in the resulting PV
Fig. 9. Compartment heterogeneity effects on
simulated PV curve. PV curves are generated for
the center slice and compartments of a single
stage III COPD subject and fitted to a monoexpo-
nential function (Eq. 10). PV curves were gener-
ated for four compartments (A) and eight com-
partments (B). The shape factor k is reported for
the center slice PV curve and the average PV
curve of the compartments. The range of compart-
ment PV curves is shown (shaded), and the max-
imum and minimum k are also reported.
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curve; a 20% decrease in L/R decreased k by 43.6% (Table
7). This limitation can be overcome in the future by acquir-
ing MR images at several b values to better estimate r, R, L,
DT, and DL (39). Finally, the assumptions that alveoli
remain spherical in COPD and that the number of duct rings
n remain equivalent to the number of alveoli N are both
debatable and strongly influence the resulting PV curve. For
example, assuming the alveoli are all hemispherical reduces k by
45.5%, and a change in the n-to-N ratio by 20% changes k by
16–19% (Table 7). Unfortunately, both of these parameters likely
change from subject to subject and cannot be determined a priori
or estimated using in vivo 3He imaging.
A final limitation with the model is that it fails to account for
heterogeneity in lung structure and micromechanics. In severe
emphysematous lungs, which are characterized as having a
wide range of ADC values and alveolar dimensions, it becomes
contentious whether a mean ADC value is truly representative
of the entire lung. We tested the representativeness of a mean
global ADC by comparing the PV curve generated at a single
slice level in a stage III COPD subject with PV curves
generated at a compartment level in the same slice (Figs. 8 and
9). The resulting compartment PV curves differed in their
shape factor k by 3% compared with the whole slice PV
curve, despite differences between compartment ADC and whole
slice ADC of up to 10%. Additionally, the average PV curve
among all of the compartments is nearly identical to the whole
slice PV curve. This result suggests that simulated whole lung PV
curves are insensitive to large-scale heterogeneity.
While regional PV curves can be generated to capture
regional differences in lung mechanics, the added issue of
ADC sensitivity to small-scale heterogeneity is raised. Com-
puting PV curves at a pixel level is problematic, as Jacob et al.
(22) had demonstrated that, at the single-pixel level, ADC is
sensitive to heterogeneity in microscopic structure rather than
true changes in alveolar dimensions. However, that group used
a pixel size of 0.5 mm  0.5 mm, with a slice thickness of 2
mm, while our pixel size was 3.125 mm  3.125 mm, with a
slice thickness of 30 mm, which might mitigate small-scale
heterogeneity effects. The same group also found that mean ADC
at larger scale correlated well with mean alveolar dimensions, and
that the Yablonskiy et al. model (48) could adequately describe
the emphysematous lung. Previous work in our laboratory (11)
has also demonstrated that heterogeneity can exist at a regional
pixel level, which is not accounted for in this present work. A
remaining question is what effect does regional heterogeneity
have on image-derived PV curves.
In future studies, it will be important to directly compare
simulated PV curves for a larger group of COPD and healthy
volunteers with PV curves acquired experimentally to better
understand the regional information we are simulating. At the
time of study, our laboratory did not have access to the
necessary equipment nor expertise to experimentally measure
PV curves in these same subjects using the transesophageal
balloon method. Conducting these measurements years after
the original scan would introduce a discrepancy between the
simulated and measured PV curve, as the patient’s lung func-
tion may have altered in that time. However, when comparing
our derived PV curves to typical measured PV curves, we do
note that our derived PV curves have much lower k values,
implying that these PV curves do not plateau as quickly as
measured ones. It may be the case that derived PV curves only
accurately describe measured PV curves at low volumes. At
the same time, it is possible that imaging-derived regionally
based PV curves might provide a way to better characterize
heterogenous or focal disease, since information is captured
from all regions of the lung and the contributions can be
evaluated independently. In other words, the transesophageal
balloon method measures Ptp contributions from the entire
lung adjacent to the lung pleural cavity. By comparing both
experimental and imaged-derived PV curves in cases with
minimal heterogeneity, such as in healthy lungs, and in cases
marked by large regional heterogeneity, such as in emphyse-
matous lungs, it would be possible to empirically determine the
effects of heterogeneity on lung mechanics.
The current result, however, demonstrated that hyperpolar-
ized 3He ADC can be used to derive alveolar dimensions on a
regional basis and generate transpulmonary PV curves using
the Stamenovic model of lung mechanics. For healthy elderly
and COPD subjects, Ptp was greater in the posterior region of
the lung than in the anterior region, and significant differences
were detected between subject groups. The results of this
preliminary analysis suggest that hyperpolarized 3He MRI may
provide an important noninvasive method for studying regional
transpulmonary PV curves in COPD.
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